Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 Mar 13;284(6318):765–766. doi: 10.1136/bmj.284.6318.765

Vasodilators in heart failure.

A Breckenridge
PMCID: PMC1496367  PMID: 6802217

Full text

PDF
765

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold S. B., Byrd R. C., Meister W., Melmon K., Cheitlin M. D., Bristow J. D., Parmley W. W., Chatterjee K. Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med. 1980 Dec 18;303(25):1443–1448. doi: 10.1056/NEJM198012183032503. [DOI] [PubMed] [Google Scholar]
  2. Chatterjee K., Parmley W. W. Vasodilator therapy for chronic heart failure. Annu Rev Pharmacol Toxicol. 1980;20:475–512. doi: 10.1146/annurev.pa.20.040180.002355. [DOI] [PubMed] [Google Scholar]
  3. Cohn J. N., Franciosa J. A. Vasodilator therapy of cardiac failure (second of two parts). N Engl J Med. 1977 Aug 4;297(5):254–258. doi: 10.1056/NEJM197708042970506. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. N., Franciosa J. A. Vasodilator therapy of cardiac failure: (first of two parts). N Engl J Med. 1977 Jul 7;297(1):27–31. doi: 10.1056/NEJM197707072970105. [DOI] [PubMed] [Google Scholar]
  5. Hanley S. P., Cowley A., Hampton J. R. Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure. Lancet. 1980 Apr 5;1(8171):735–736. doi: 10.1016/s0140-6736(80)91232-5. [DOI] [PubMed] [Google Scholar]
  6. Kirlin P. C., Pitt B. Hemodynamic effects of intravenous prenalterol in severe heart failure. Am J Cardiol. 1981 Mar;47(3):670–675. doi: 10.1016/0002-9149(81)90553-1. [DOI] [PubMed] [Google Scholar]
  7. Klausner S. C., Ratshin R. A., Tyberg J. V., Lappin H. A., Chatterjee K., Parmley W. W. The similarity of changes in segmental contraction patterns induced by postextrasystolic potentiation and nitroglycerin. Circulation. 1976 Oct;54(4):615–623. doi: 10.1161/01.cir.54.4.615. [DOI] [PubMed] [Google Scholar]
  8. MacCannell K. L., McNay J. L., Meyer M. B., Goldberg L. I. Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966 Dec 22;275(25):1389–1398. doi: 10.1056/NEJM196612222752501. [DOI] [PubMed] [Google Scholar]
  9. Mason D. T. Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective. Am J Med. 1978 Jul;65(1):101–105. doi: 10.1016/0002-9343(78)90699-x. [DOI] [PubMed] [Google Scholar]
  10. Parmley W. W., Chuck L., Chatterjee K., Swan H. J., Klausner C., Glantz S. A. Acute changes in the diastolic pressure-volume relationship of the left ventricle. Eur J Cardiol. 1976 May;4 (Suppl):105–120. [PubMed] [Google Scholar]
  11. Tuttle R. R., Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975 Jan;36(1):185–196. doi: 10.1161/01.res.36.1.185. [DOI] [PubMed] [Google Scholar]
  12. Zelis R., Flaim S. F., Moskowitz R. M., Nellis S. H. How much can we expect from vasodilator therapy in congestive heart failure? Circulation. 1979 Jun;59(6):1092–1097. doi: 10.1161/01.cir.59.6.1092. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES